Residual symptoms in depressed patients who respond acutely to fluoxetine

Journal of Clinical Psychiatry

Volumn 60, Issue 4, 1999, Pages 221-225

  Nierenberg, Andrew A ^a   Keefe, Bronwyn R ^a   Leslie, Vinita C ^a   Alpert, Jonathan E ^a   Pava, Joel A ^a   Worthington III, John J ^a   Rosenbaum, Jerrold F ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE;

ADULT; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SYMPTOM; TREATMENT FAILURE;

EID: 0032908414     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n0403     Document Type: Article

References (16)

1. Frank E, Karp J, Rush A. Efficacy of treatments for major depression. Psychopharmacol Bull 1993;29:457-475
2. Clinical Practice Guideline Number 5, Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
3. Trivedi M, Rush A. A review of randomized controlled medication trials in major depression [abstract]. Biol Psychiatry 1992;31:188A-189A
4. Fava GA, Grandi S, Zielezny M, et al. Cognitive-behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994;151:1295-1299
5. Rush A, Trivedi M. Treating depression to remission. Psychiatr Ann 1995; 25:704-710
6. Judd L, Akiskal H, Paulus M. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 1997;45:5-18
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
8. Stassen H, Angsl J, Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiatry 1996;29:87-96
9. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-855
10. Thase ME, Simons AD, McGeary J, et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992;149:1046-1052
11. Pava J, Nierenberg A, Carey M, et al. Residual symptoms in major depression: a comparison with normal controls. Presented at the 147th annual meeting of the American Psychiatric Association; May 22-26, 1994, Philadelphia, Pa
12. Shea T, Leon A, Mueller T, et al. Does major depression result in lasting personality change? Am J Psychiatry 1996;153:1404-1410
13. Spitzer R, Williams J, Gibbon M, et al. Structured Clinical Interview for DSM-III-R, Patient Version (SCID-P, 9/1/89). New York, NY: Biometric Research, New York State Psychiatric Institute; 1989
14. Stewart J, McGrath P, Quitkin F. Can mildly depressed patients with atypical depression benefit from antidepressants? Am J Psychiatry 1992;149: 615-619
15. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II, 9/1/89). New York, NY: Biometric Research, New York State Psychiatric Institute; 1989
16. Horwath E, Johnson J, Klerman G, et al. Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry 1992;49:817-823